PharmaTech

JUNE 9, 2025

Challener News Article Pharmaceutical Technology Pharmaceutical Technology June 2025 Volume 49 Issue 5 Unique surface properties and ligand functionalization provide real advantages. 2025 19 (4). Efficient and effective delivery of complex and challenging drug substances is an ongoing issue facing developers of modern medicines.

Dosage 52

Dosage Drug Development Immunization Immunity 52

Pharmacy Times

JUNE 11, 2025

Zanubrutinib tablets are set to replace capsules beginning in October 2025, according to the news release. Released June 11, 2025. Accessed June 11, 2025. Package insert. Accessed June 11, 2025. FDA approves tablet formulation of BeOne's BRUKINSA for all approved indications. News Release. BeiGene USA, Inc.;

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Biosimilars Pharmacy Management 26

The Thyroid Pharmacist

MARCH 7, 2025

10] Its not only found in obvious sources like plastic containers and packaging, but also in the lining of canned foods and drinks, receipts, toys, electronics, and household items. When grocery shopping, try to purchase items that are packaged in glass and canned foods that are packaged with BPA-free lining. 2024;23(1):22-26.

Health and Personal Care Stores 66

Health and Personal Care Stores Labelling Immunization Immunity 66

Pharmaceutical Technology

JUNE 13, 2025

GlobalData Healthcare June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook There are currently no curative therapies for MG. The myasthenia gravis (MG) market across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and the US) is poised to grow at a compound annual growth rate of 5.3%

Biosimilars 52

Biosimilars Communication Hospitals Vaccines 52

Pharmaceutical Technology

MARCH 22, 2023

According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

PharmaTech

JUNE 12, 2025

Moving and shaking The deal, approved unanimously by the boards of both companies, is expected to close in 2025, pending customary regulatory clearances and a minimum 80% share acceptance rate from CureVac shareholders—although BioNTech retains the option to reduce this threshold to 75% (1). June 12, 2025. billion (1). Press Release.

Dosage 52

Dosage Drug Development Vaccines Packaging 52

PharmaTech

JUNE 10, 2025

The global biopharma industry is expected to increase at a compound annual growth rate of 8.97% from 2025 to 2030; this growth is suspected to result from a demand for targeted therapies, new alliances, and increased innovation (1). Grandviewresearch.com (accessed May 19, 2025). Next-Generation Biotherapeutics eBook 2025 April.

Dosage 52

Dosage Drug Development Vaccines Compounding 52

Pharmaceutical Technology

JUNE 13, 2025

Robert Barrie June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook AstraZeneca and CSPC will discover and develop pre-clinical candidates for multiple targets. In March 2025, the drugmaker revealed plans to infuse $2.5bn over the next five years in Beijing to establish an R&D hub.

Communication 95

Communication Hospitals Vaccines Packaging 95

PharmaTech

JUNE 12, 2025

Image Credit: © Tada Images - stock.adobe.com In a June 10, 2025 update, FDA posted seven updated Warning Letters, issued between the beginning of 2025 and the present, to its online database, which stores more than 3400 such letters dating back to 2020 (1). American Behavioral Research Institute Boca Raton, Fla. –

Dosage 59

Dosage Drug Development Labelling Compounding 59

PharmaTech

JUNE 11, 2025

June 11, 2025. ELK1 (accessed June 11, 2025). Major Depression (accessed June 11, 2025). Elkedonia Closes EUR 11 Million Seed Round to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders. Press Release. National Institute of Mental Health.

Dosage 52

Dosage Drug Development Packaging Vaccines 52

Pharmaceutical Business Review

MAY 5, 2025

PCI has been developing its capabilities in this area, having established a new pharmaceutical development lab for potent and non-potent compounds at its Bedford, New Hampshire facility. These facilities are expected to be GMP ready by fall 2025.

Packaging 52

Packaging Compounding 52

Pharmacy Times

JUNE 5, 2025

Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. 2 A prominent aspect of this issue that manufacturers have tried to tackle is medication recognition when transferring pills to containers and packaging. 1-3 Detect-A-Dose Lid Label Covers.

Pharmacy Technician 26

Pharmacy Technician Packaging Labelling Immunization 26

The Thyroid Pharmacist

APRIL 11, 2025

It contains many phenolic compounds which possess substantial anti-inflammatory and antioxidant effects. However, please note that Wobenzym is currently experiencing a shortage as of Apr 2025, so Rootcology Systemic Enzymes is a great alternative. Accessed March 28, 2025. SpringerOpen. June 20, 2024. link] [21] Panda S, Kar A.

Immunization 70

Immunization Immunity Dosage Diabetes 70

Ramblings of a pharmacist

MAY 16, 2025

I work at Jolley’s Compounding Pharmacy, which my grandpa started over 70 years ago, making us the third oldest pharmacy in Utah. In December, it was included in the budget package, and I started to get hopeful that pharmacists would see change. ” That was April 13, 2025. I’m a pharmacist.

Specialty Pharmacies 122

Specialty Pharmacies Compounding Pharmacies Packaging Compounding 122